Antiviral Prophylaxis and Infant Vaccination to Prevent Perinatal Hepatitis B Infection

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

August 2, 2018

Primary Completion Date

May 13, 2023

Study Completion Date

June 30, 2025

Conditions
Hepatitis BPregnancy
Interventions
DRUG

Anti-HBV antiviral prophylaxis

Tenofovir disoproxil fumarate (TDF), one 300 mg tablet once a day from 28 weeks' gestation through two months postpartum

Trial Locations (20)

10230

Nopparat Rajathanee Hospital, Bangkok

10280

Samutprakarn Hospital, Mueang Samut Prakan

20000

Chonburi Hospital, Chon Buri

20150

Banglamung Hospital, Chon Buri

22000

Prapokklao Hospital, Chanthaburi

50100

Health Promotion Center Region 1, Chiang Mai

50180

Nakornping Hospital, Chiang Mai

51000

Lamphun Hospital, Lamphun

52000

Lampang Hospital, Lampang

56110

Chiang Kham Hospital, Chiang Kham

57000

Chiangrai Prachanukroh Hospital, Chiang Rai

74000

Samutsakhon Hospital, Samut Sakhon

Unknown

Champasak Hospital, Champasak

Luang Prabang Provincial Hospital, Luang Prabang

Sayaboury Hospital, Sainyabuli

Savannakhet Provincial hospital, Savannakhet

103 Hospital, Vientiane

Mahosot Hospital, Vientiane

Mother and Newborn Hospital, Vientiane

Setthathirath Hospital, Vientiane

All Listed Sponsors
collaborator

Chiang Mai University

OTHER

collaborator

Ministry of Health, Thailand

OTHER_GOV

collaborator

Ministry of Health, Lao PDR

UNKNOWN

lead

Institut de Recherche pour le Developpement

OTHER_GOV